Clinical Trials Browser

Interventional × Neuroendocrine Tumors × Lysine × Clear all

NCT03478358 2022-08-31

Treatment Using 177Lu-DOTA-EB-TATE in Patients With Advanced Neuroendocrine Tumors

Phase 1 Unknown

Neuroendocrine Tumors